21:43:32 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for Jan. 23, 2015

2015-01-23 20:50 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange fell a fraction to 678.18 Friday, ending the week up 10.87 points. Laurie Sadler's halted capital pool shell, Valiant Minerals Ltd. (VTM), has finally submitted an information circular detailing its plan to acquire Convalo Health International Corp., the owner of a rehab clinic in Hollywood, as its qualifying transaction.

Convalo owns the BLVD Center in Hollywood, where it offers the usual 12-step recovery approach. It has also designed programs that are "gender specific, creatively oriented, medication/mindfulness and LGBT affirmative." There must be plenty of money to be made in the rehab business. BLVD currently charges $1,000 (U.S.) a day for the basic outpatient program services, $1,595 (U.S.) a day for intensive outpatient program services and $2,400 (U.S.) a day for the real basket cases, partial hospitalization program services. Most of these fees are covered by insurance companies that now must treat alcoholism and drug addiction as diseases. BLVD says that in its fourth quarter of 2014 it averaged 10 clients a month, generating a monthly gross profit of $165,000. Those numbers are unaudited. The most recent audited financials available are for the nine-month period ended Aug. 31, 2014, when Convalo lost $1.21-million on revenue $436,123, but the loss includes start-up costs for the rehab clinic, which opened in the spring of 2014. The company plans to open two new BLVD Centers this year, so the founders evidently have high hopes.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed